CLINICAL_TRIALS
research
· 2026-03-31
Clinical Trial Update: Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD) [Phase 2]
Summary
A Phase 2 trial evaluating add-on Rademikibart for acute exacerbations of chronic obstructive pulmonary disease is currently recruiting (NCT06940154).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Connect Biopharm LLC | Conditions: COPD Acute Exacerbation | Phase 2 | Status: RECRUITING